Clinical Trials Logo

Bile Duct Diseases clinical trials

View clinical trials related to Bile Duct Diseases.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05600270 Completed - Bile Duct Diseases Clinical Trials

Angled-tip vs. Straight-tip Guidewire in Biliary Cannulation

Start date: October 22, 2022
Phase: N/A
Study type: Interventional

The investigators aim is to compare outcomes between an angled-tip guidewire and a straight-tip guidewire in cannulation of the common bile duct during ERCP. This is a randomized, controlled, single-blinded study. The primary outcome is success of cannulation and secondary outcomes are incidence of post-ERCP pancreatitis, procedure duration, and rate of complication between the angled wire and straight wire.

NCT ID: NCT05263752 Completed - Bile Duct Diseases Clinical Trials

Evaluation of Safety and Efficacy of NvisionVLE® Imaging Low Profile System in Patients With Bile Duct Disease

Start date: October 18, 2017
Phase:
Study type: Observational [Patient Registry]

A previous study evaluating the NvisionVLE® Imaging Low Profile System revealed the system to be feasible and safe for use in bile duct. The study also revealed a potential to better define abnormalities, target sampling and therapy when utilizing the NvisionVLE® Imaging Low Profile System. This study will further evaluate the safety and efficacy of the NvisionVLE® Imaging Low Profile System in patients with bile duct diseases.

NCT ID: NCT05147389 Completed - Clinical trials for Common Bile Duct Neoplasms

Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis

Start date: October 1, 2020
Phase:
Study type: Observational [Patient Registry]

Digital single-operator cholangioscopy (DSOC) findings achieve high diagnostic accuracy for neoplastic bile duct lesions. To date, there is not a universally accepted DSOC classification. Endoscopists' Intra and interobserver agreements vary widely. Cholangiocarcinoma (CCA) assessment through artificial intelligence (AI) tools is almost exclusively for intrahepatic CCA (iCCA). Therefore, more AI tools are necessary for assessing extrahepatic neoplastic bile duct lesions. In Ecuador, the investigators have recently proposed an AI model to classify bile duct lesions during real-time DSOC, which accurately detected malignancy patterns. This research pursues a clinical validation of our AI model for distinguishing between neoplastic and non-neoplastic bile duct lesions, compared with high DSOC experienced endoscopists.

NCT ID: NCT04580940 Completed - Pancreatic Diseases Clinical Trials

SpyGlass™ Discover Percutaneous

Start date: July 27, 2021
Phase:
Study type: Observational [Patient Registry]

To document the clinical utility of percutaneous cholangiopancreatoscopy using a thin, disposable, flexible endoscope for evaluation and treatment of complex pancreaticobiliary disease in a prospective, multi-center case series

NCT ID: NCT04341909 Completed - Pancreas Cancer Clinical Trials

Trainee Involvement in ERCP Risk Score

TIERS
Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

The study aims to evaluate factors associated with an increased risk of procedure related adverse events (including tecnical failure) of endoscopic retrograde cholangiopancreatography procedures (ERCP) conducted in a teaching setting, with trainee involvement.

NCT ID: NCT04145843 Completed - Bile Duct Diseases Clinical Trials

Treatment Outcomes in Bile Duct Stones

Start date: November 6, 2019
Phase:
Study type: Observational

This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic treatment of bile duct stones when utilizing an algorithmic management approach.

NCT ID: NCT04040504 Completed - Bile Duct Diseases Clinical Trials

Infection Control in ERCP Using a Duodenoscope With a Disposable Cap

ICECAP
Start date: December 3, 2019
Phase: N/A
Study type: Interventional

1. Background & Rationale Over 650,000 endoscopic retrograde cholangio-pancreatography (ERCP) procedures are performed annually in the United States alone. ERCP is universally performed using a highly specialized type of flexible endoscope called a duodenoscope. Though critical for the successful completion of ERCP, the design of duodenoscopes makes them among the most complicated medical devices that require routine disinfection and reprocessing. In recent years, several ERCP-related infectious outbreaks have occurred. Thus, it is clear that novel strategies need to be developed in order to prevent future ERCP-related outbreaks. Specialized duodenoscopes with disposable caps have been developed, and these represent a promising new modality with the potential to drastically reduce the rates of duodenoscope-related infection. 2. Research Questions & Objectives There are two co-primary outcomes in this study; the first is to determine the clinical efficacy of a novel duodenoscope with a disposable elevator cap (DEC) system compared with a duodenoscope with a traditional design. The second co-primary objective is to determine the rate of persistent pathogenic contamination of the novel duodenoscope following standardized disinfection and reprocessing protocols compared with a traditional duodenoscope. 3. Methods This is a prospective, consecutive, randomized controlled study. The intervention arm will comprise use of the ED34-i10T2 duodenoscope with DEC, along with any required standard ERCP accessories, whereas the control arm will comprise use of the ED34-i10T duodenoscope with any required ERCP accessories. All procedures will be performed by expert endoscopists with adequate training, or by advanced endoscopy trainees under direct supervision. Collected data will include primary endpoints listed above, in addition to patient demographics, endoscopist and trainee data, sedation used, procedural details, and peri-procedural data. Data will be collected at index procedure and at 30-day follow-up. All data will be recorded on REDCap.

NCT ID: NCT03775681 Completed - Clinical trials for Endocrine Pancreas Disorder

Feasibility of Laryngeal Mask Airway Gastro on Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Pancreas and Bile Duct Disorders

Start date: January 16, 2019
Phase: N/A
Study type: Interventional

This trial determines the feasibility of Laryngeal Mask Airway Gastro (Laryngeal Mask Airway) when used on patients who are undergoing endoscopic retrograde cholangiopancreatography for pancreas and bile duct disorders. Laryngeal Mask Airway is a device that helps patients breathe while they are asleep during procedures.

NCT ID: NCT02967926 Completed - Clinical trials for Cholangitis, Sclerosing

Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy

Start date: December 2015
Phase: Phase 3
Study type: Interventional

This study aim to evaluated the effectiveness of Digital SpyGlass Cholangioscopy to facilitate common bile duct stone removal without fluoroscopy

NCT ID: NCT02917408 Completed - Liver Cirrhosis Clinical Trials

Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital

Start date: September 2016
Phase:
Study type: Observational

Retrospective study of all patients diagnosed with primary biliary cholangitis during January 2001 to July 2016 at West China Hospital by review of medical records. The following variables will be retrospectively studied: age, sex, first symptoms, clinical characteristics, pathology, treatment, stage, complications of cirrhosis, other autoimmune diseases and long-term outcome.